(S (NP (NNP HIV-1)) (VP (MD can) (VP (VB disseminate) (PP (IN between) (NP (JJ susceptible) (NNS cells))) (PP (IN by) (NP (NP (CD two) (NNS mechanisms)) (: :) (NP (NP (NP (JJ cell-free) (NN infection)) (PP (VBG following) (NP (NP (JJ fluid-phase) (NN diffusion)) (PP (IN of) (NP (NNS virions)))))) (CC and) (PP (IN by) (NP (NP (JJ highly-efficient) (JJ direct) (NN cell-to-cell) (NN transmission)) (PP (IN at) (NP (NN immune) (NN cell) (NNS contacts)))))))))) (. .))
(S (NP (NP (DT The) (NN contribution)) (PP (IN of) (NP (NP (DT this) (JJ hybrid) (NN spreading) (NN mechanism)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADVP (RB also)) (NP (NP (DT a) (NN characteristic)) (PP (IN of) (NP (DT some) (JJ important) (NN computer) (NN worm) (NNS outbreaks))))))) (, ,))) (PP (TO to) (NP (NP (NNP HIV-1) (NN progression)) (PP (IN in) (NP (NN vivo)))))) (VP (VBZ remains) (ADJP (JJ unknown))) (. .))
(S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP present) (NP (NP (DT a) (JJ new) (JJ mathematical) (NN model)) (SBAR (WHNP (WDT that)) (S (VP (ADVP (RB explicitly)) (VBZ incorporates) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NNP HIV-1))) (S (VP (TO to) (VP (VP (VB use) (NP (JJ hybrid) (VBG spreading) (NNS mechanisms))) (CC and) (VP (VB evaluate) (NP (NP (DT the) (NNS consequences)) (PP (IN for) (NP (NNP HIV-1) (NN pathogenenesis)))))))))))))) (. .))
(S (NP (DT The) (NN model)) (VP (VP (VBZ captures) (NP (NP (DT the) (JJ major) (NNS phases)) (PP (IN of) (NP (NP (DT the) (NNP HIV-1) (NN infection) (NN course)) (PP (IN of) (NP (NP (DT a) (NN cohort)) (PP (IN of) (NP (ADJP (NN treatment) (JJ naive)) (NNS patients))))))))) (CC and) (ADVP (RB also)) (VP (ADVP (RB accurately)) (VBZ predicts) (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (DT the) (NNP Short) (NNP Pulse) (JJ Anti-Retroviral) (NNP Therapy) (PP (IN at) (NP (NNP Seroconversion))) (PRN (-LRB- -LRB-) (NP (NNP SPARTAC)) (-RRB- -RRB-)) (NN trial)))))) (. .))
(S (S (VP (VBG Using) (NP (DT this) (NN model)))) (NP (PRP we)) (VP (VBP find) (SBAR (SBAR (IN that) (S (NP (JJ hybrid) (NN spreading)) (VP (VBZ is) (ADJP (JJ critical) (S (VP (TO to) (VP (NN seed) (CC and) (VB establish) (NP (NN infection))))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NP (JJ cell-to-cell) (NN spread)) (CC and) (NP (VBD increased) (NNP CD4+) (NNP T) (NN cell) (NN activation))) (VP (VBP are) (ADJP (JJ important) (PP (IN for) (NP (NNP HIV-1) (NN progression))))))))) (. .))
(S (ADVP (RB Notably)) (, ,) (NP (DT the) (NN model)) (VP (VBZ predicts) (SBAR (IN that) (S (NP (NN cell-to-cell) (NN spread)) (VP (VP (VBZ becomes) (ADJP (RB increasingly) (JJ effective)) (SBAR (IN as) (S (NP (NN infection)) (VP (NNS progresses))))) (CC and) (VP (ADVP (RB thus)) (MD may) (VP (VB present) (NP (DT a) (JJ considerable) (NN treatment) (NN barrier)))))))) (. .))
(S (S (VP (VBG Deriving) (NP (NP (NNS predictions)) (PP (IN of) (NP (NP (NP (JJ various) (NNS treatments) (POS â€º)) (NN influence)) (PP (IN on) (NP (NNP HIV-1) (NN progression)))))))) (VP (VP (VBZ highlights) (NP (NP (DT the) (NN importance)) (PP (IN of) (NP (JJR earlier) (NN intervention))))) (CC and) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (NNS treatments)) (VP (ADVP (RB effectively)) (VBG targeting) (NP (JJ cell-to-cell) (NNP HIV-1) (NN spread)))) (VP (MD can) (VP (VB delay) (NP (NP (NN progression)) (PP (TO to) (NP (NNP AIDS)))))))))) (. .))
(S (NP (DT This) (NN study)) (VP (VP (VBZ suggests) (SBAR (IN that) (S (NP (JJ hybrid) (NN spreading)) (VP (VBZ is) (NP (NP (DT a) (JJ fundamental) (NN feature)) (PP (IN of) (NP (NNP HIV) (NN infection)))))))) (, ,) (CC and) (VP (VBZ provides) (NP (NP (DT the) (JJ mathematical) (NN framework)) (VP (VBG incorporating) (NP (DT this) (NN feature))) (SBAR (WHPP (IN with) (WHNP (WDT which))) (S (VP (TO to) (VP (VB evaluate) (NP (JJ future) (JJ therapeutic) (NNS strategies))))))))) (. .))
